Akynzeo 300-0.5 MG capsules
Ended Awarded
- Contract number
- SPE2DB25FJG26
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,292
Award facts
- Contract value 100% obligated
- $17,291.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $17,291.71 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of AKYNZEO 300-0.5 mg capsules, a pharmaceutical product used in oncology and chemotherapy-related nausea and vomiting management. This competitively awarded, firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's comprehensive SPE2DX contract vehicle enables supply of a broad range of pharmaceutical products and medical commodities including specialty medications, vaccines, and medical devices to support Defense Health Agency and other government healthcare systems worldwide. This delivery order reflects the company's ongoing role in fulfilling specialized pharmaceutical requirements for federal military healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FJG26?
SPE2DB25FJG26 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FJG26 worth?
The government has obligated $17,292 on SPE2DB25FJG26.
Is contract SPE2DB25FJG26 an order under another contract?
Yes. SPE2DB25FJG26 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJG26 competed?
The extent of competition for SPE2DB25FJG26 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award